First-line nivolumab + ipilimumab in advanced NSCLC: CheckMate 227 subpopulation analyses in Asian patients

K. J. O'Byrne, K. H. Lee, S. W. Kim, K. Park, M. Nishio, H. Sakai, Y. Ohe, T. Fukuhara, J. H. Kang, H. Daga, C. J. Yu, K. Hotta, H. Tanaka, M. Takeda, T. Yokoyama, F. E. Nathan, J. S. Lee

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'First-line nivolumab + ipilimumab in advanced NSCLC: CheckMate 227 subpopulation analyses in Asian patients'. Together they form a unique fingerprint.

Medicine & Life Sciences